These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 33298400)

  • 1. Vaccinology - Editorial.
    Pizza M; Rappuoli R
    Semin Immunol; 2020 Aug; 50():101439. PubMed ID: 33298400
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccines for SARS coronavirus 2 and the new normal in vaccinology.
    Griffiths PD
    Rev Med Virol; 2021 Mar; 31(2):e2229. PubMed ID: 33666285
    [No Abstract]   [Full Text] [Related]  

  • 3. The lightning-fast quest for COVID vaccines - and what it means for other diseases.
    Ball P
    Nature; 2021 Jan; 589(7840):16-18. PubMed ID: 33340018
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: Challenges in Vaccinology.
    Lavelle EC; Carsetti R; Pickl WF; Wiedermann U
    Front Immunol; 2020; 11():632537. PubMed ID: 33391292
    [No Abstract]   [Full Text] [Related]  

  • 5. How COVID unlocked the power of RNA vaccines.
    Dolgin E
    Nature; 2021 Jan; 589(7841):189-191. PubMed ID: 33437061
    [No Abstract]   [Full Text] [Related]  

  • 6. The immunology of SARS-CoV-2 infections and vaccines.
    Grigoryan L; Pulendran B
    Semin Immunol; 2020 Aug; 50():101422. PubMed ID: 33262067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccines: acting on the evidence.
    Nat Med; 2021 Feb; 27(2):183. PubMed ID: 33542537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA vaccine for cancer immunotherapy.
    Miao L; Zhang Y; Huang L
    Mol Cancer; 2021 Feb; 20(1):41. PubMed ID: 33632261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2.
    Rubin EJ; Baden LR; Abraham J; Morrissey S
    N Engl J Med; 2021 Mar; 384(10):e48. PubMed ID: 33704945
    [No Abstract]   [Full Text] [Related]  

  • 10. The Bone Marrow as Sanctuary for Plasma Cells and Memory T-Cells: Implications for Adaptive Immunity and Vaccinology.
    Slamanig SA; Nolte MA
    Cells; 2021 Jun; 10(6):. PubMed ID: 34203839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and deployment of COVID-19 vaccines for those most vulnerable.
    Koff WC; Schenkelberg T; Williams T; Baric RS; McDermott A; Cameron CM; Cameron MJ; Friemann MB; Neumann G; Kawaoka Y; Kelvin AA; Ross TM; Schultz-Cherry S; Mastro TD; Priddy FH; Moore KA; Ostrowsky JT; Osterholm MT; Goudsmit J
    Sci Transl Med; 2021 Feb; 13(579):. PubMed ID: 33536277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement Factors in COVID-19 Therapeutics and Vaccines.
    Kurtovic L; Beeson JG
    Trends Immunol; 2021 Feb; 42(2):94-103. PubMed ID: 33402318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Highly Conserved SARS-CoV-2 Antigenic Epitopes with Wide Coverage Using Reverse Vaccinology Approach.
    Hisham Y; Ashhab Y; Hwang SH; Kim DE
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies.
    Squire JD; Joshi AY
    J Clin Immunol; 2021 Oct; 41(7):1527-1530. PubMed ID: 34291391
    [No Abstract]   [Full Text] [Related]  

  • 15. The Immunologists' Guide to Pandemic Preparedness.
    Marín-Hernández D; Hupert N; Nixon DF
    Trends Immunol; 2021 Feb; 42(2):91-93. PubMed ID: 33358277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-guided structure-based vaccines.
    Kwong PD; DeKosky BJ; Ulmer JB
    Semin Immunol; 2020 Aug; 50():101428. PubMed ID: 33246736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging concepts in the science of vaccine adjuvants.
    Pulendran B; S Arunachalam P; O'Hagan DT
    Nat Rev Drug Discov; 2021 Jun; 20(6):454-475. PubMed ID: 33824489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From mRNA sensing to vaccines.
    Fauci AS; Merad M; Swaminathan S; Hur S; Topol E; Fitzgerald K; Reis e Sousa C; Corbett KS; Bauer S
    Immunity; 2021 Dec; 54(12):2676-2680. PubMed ID: 34739870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing SARS-CoV-2.
    Poeschla E
    Elife; 2020 Dec; 9():. PubMed ID: 33320086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming vaccine development.
    Black S; Bloom DE; Kaslow DC; Pecetta S; Rappuoli R
    Semin Immunol; 2020 Aug; 50():101413. PubMed ID: 33127296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.